top of page


Bioramics is a biotechnology company focused on advancing a portfolio of soft tissue regeneration and disease programs, including Dystrophix, an injectable hypoxia mimetic for the treatment of Limb Girdle and peripheral muscles of Duchenne, pyr341, a stent coating that prevents calcification, and Anaram, an injectable therapeutic to enhance soft tissue regeneration in animals. Bioramics aims to be the hub for comprehensive applications of bio-compatible ceramics, safe for injection into soft tissues. Our team is positioned to make an incredible impact in the lives of those suffering from soft tissue injuries and diseases.


Soft Tissue Regeneration

Muscle Dystrophy (Limb Girdle and Duchenne’s)

Wound Healing

Cardiovascular Disease

bottom of page